Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel

By Shepherd James   Betteridge John   Van Gaal Luc    

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 665-682

Informa Healthcare

Access to resources Recommend Favorite

Reducing coronary risk by raising HDL-cholesterol: risk modelling the addition of nicotinic acid to existing therapy

By Belsey Jonathan   de Lusignan Simon   van Vlymen Jeremy   Chan Tom   Hague Nigel  

Current Medical Research and Opinion, Vol. 24, Iss. 9, 2008-09 ,pp. : 2703-2709

Informa Healthcare

Access to resources Recommend Favorite

Significance of High‐Density Lipoprotein Cholesterol*

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 26, Iss. 10, 1978-10 ,pp. : 440-442

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cholesteryl ester transfer protein inhibitors: new strategies for raising high-density lipoprotein cholesterol

By Mabuchi Hiroshi   Inazu Akihiro  

Future Lipidology, Vol. 1, Iss. 4, 2006-08 ,pp. : 487-500

Future Medicine

Access to resources Recommend Favorite

Non-high-density-lipoprotein cholesterol and cardiovascular risk factors among adolescents with and without impaired fasting glucose

By Liu Jian   Joshi Divya   Sempos Christopher T.  

Applied Physiology, Nutrition, and Metabolism, Vol. 34, Iss. 2, 2009-04 ,pp. : 136-142

NRC Research Press

Access to resources Recommend Favorite